The UK NHS will create a national cloud platform to test artificial intelligence (AI) in screening services, aiming to end the patchwork of small pilots that has slowed adoption. The AI Research Screening Platform (AIR-SP) will enable trusts around England to run the same trials at the same time in a single secure environment, rather than building different IT for each study. The programme is backed by £6m from the National Institute for Health and Care Research (NIHR) and is due to open for research use in 2027.
Ministers say the move tackles a practical barrier: most AI tools never get beyond pilots because each site must set up temporary infrastructure and new image databases before any testing can begin. Government figures put the failure rate at around 90 per cent. AIR-SP will host multiple tools centrally and connect to trusts over secure links, which will cut the risk of duplication, significantly reduce study costs, and accelerate the approval process of technology for conditions where early intervention is paramount.
“The AI revolution is here, and we are arming staff with the latest ground-breaking technology, so patients get faster and smarter cart,” announed Health Secretary Wes Streeting “This new cloud platform will see [lifesaving] AI tools rolled out to patients in research trials right across the country, so staff can treat patients quicker with cutting-edge tech.”
AIR-SP’s first major use case will support an NIHR-funded breast screening study involving nearly 700,000 women, evaluating whether AI can help flag early signs of cancer for further assessment. Officials say the shared platform should save £2–3m per multi-site study compared with bespoke set-ups, and make it easier to evaluate several products in parallel.
For frontline services, faster introduction of proven tools will be implemented in areas where early detection changes outcomes, from cancer pathways to image-heavy programmes across the screening portfolio. For researchers and developers, a single route into multi-centre NHS trials should simplify governance and shorten time to evidence.
AIR-SP sits within a wider push to modernise the health service, including early-warning systems for patient safety and new non-invasive diagnostics. But officials stress that centralising trials is the practical step needed now to move from many pilots to system-wide adoption with consistent safeguards on consent, security and performance. If the model works, validated tools will have a clearer path from trials to clinical use across the country.